JANUARY 12, 2018
Eric Bieber, MD
President and CEO
Rochester Regional Health
As we continue to invest in traditional healthcare initiatives across the system to meet the needs of the residents of the region—like the Sands-Constellation Center for Critical Care, the newly opened Henrietta Medical Campus and the Wegman’s Center for Workforce Development—we also are focused on innovative investments that will position us well for sustainable future growth.
One such investment is our recent acquisition of Philadelphia-based DrugScan International. DrugScan is a best-in-breed toxicology laboratory testing company with a thirty-year track record of delivering innovative medication monitoring solutions to healthcare providers across the United States. As toxicology testing demand grows in the wake of the national opioid epidemic, health systems nationally will need to partner with innovative companies like DrugScan to help providers manage and treat patients with complex medication needs. Adding DrugScan to our ACM Global Laboratories portfolio positions Rochester Regional Health to lead the way on the front lines of the opioid crisis here and across the nation.
DrugScan also expands our global footprint to include more US markets and expand our ACM Global Laboratory capabilities. With the world headquarters right here in Rochester, and key locations in York, England; Shanghai, China; Mumbai, India; and Singapore, ACM Global Laboratories expands the reach of Rochester Regional Health across the globe and provides a growing, positive revenue stream to the health system.
Thank you all for everything you do each and every day to deliver high quality, safe care. I am proud to work alongside you to enhance the lives and preserve the health of all those we serve.
Eric Bieber, MD
President/CEO Rochester Regional Health